Senior insider sale
President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$30.42M
914.01K shares
What this filing means
FRANCIS RICHARD D plans to sell 914.01K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $30.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001973379-26-000084
Officer· President and CEO
Since Mar 2026
914.01K
Shares to sell
$30.42M
Approx. market value
50.22K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RESTRICTED SHARE UNIT AWARD VESTING
COMPENSATION
3/4/2024
50.22KTotal acquired50.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2024 | RESTRICTED SHARE UNIT AWARD VESTING COMPENSATION | 50.22K | — |
| Total | 50.22K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
442.94K
Market value
$14.33M
3/3/2026
—Completed
Units to sell
447.68K
Market value
$15.32M
2/17/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
23.39K
Market value
$759.4K
3/4/2026
Total
Units
914.01K
Value
$30.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 442.94K | $14.33M | — | Completed |
2/17/2026 | 447.68K | $15.32M | — | Completed |
| Planned — Approximate Date | ||||
3/4/2026 | 23.39K | $759.4K | NYSE | Planned |
| Total | 914.01K | $30.42M | ||